BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8697990)

  • 1. [Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization].
    Yang S; Wang M; You W
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):415-7. PubMed ID: 8697990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma.
    Wu B; Wang M; You W; Yang S
    Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness.
    Hsu HC; Tseng HJ; Lai PL; Lee PH; Peng SY
    Cancer Res; 1993 Oct; 53(19):4691-4. PubMed ID: 8402647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
    Chan KL; Guan XY; Ng IO
    Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC].
    Dai D; Zhai W; Zhu T; Zhu H; Ling Y
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():79-81. PubMed ID: 11509149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of expression of eight p53-related genes in hepatocellular carcinoma with tissue microarrays].
    Zhu MH; Ni CR; Zhu Z; Li FM; Zhang SM
    Ai Zheng; 2003 Jul; 22(7):680-5. PubMed ID: 12866955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase and c-myc expression in hepatocellular carcinomas.
    Liu YC; Chen CJ; Wu HS; Chan DC; Yu JC; Yang AH; Cheng YL; Lee SC; Harn HJ
    Eur J Surg Oncol; 2004 May; 30(4):384-90. PubMed ID: 15063891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the expression of oncogene mRNA in hepatocellular carcinoma using in situ hybridization technique].
    Hayashi D
    Nihon Geka Gakkai Zasshi; 1994 Nov; 95(11):814-22. PubMed ID: 7830708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The correlation between integration of HBV X, S, Pre-S, C gene and the expression of oncogenes/tumor suppressor genes in primary hepatocellular carcinoma].
    Zhang L; Cao Y; Song J
    Zhonghua Gan Zang Bing Za Zhi; 1999 Sep; 7(3):138-9. PubMed ID: 10572677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies.
    Miyazaki S; Sasno H; Shiga K; Sawai T; Nishihira T; Okamoto H; Mori S
    Anticancer Res; 1992; 12(5):1747-55. PubMed ID: 1444241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [WAF1/CIP1 gene expression in human hepatocellular carcinoma and its relationship with p53 mutation].
    Zhu B; Cong W; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):217-20. PubMed ID: 10715791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of c-myc gene expression in nasopharyngeal carcinoma by nonradioactive in situ hybridization and immunohistochemistry.
    Luo J; Xiao J; Tao Z; Li X
    Chin Med J (Engl); 1997 Mar; 110(3):229-32. PubMed ID: 9594347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.
    Ikeguchi M; Hirooka Y
    Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of p53 alteration and myc family gene overexpression with the clinical characteristics of lung cancer.
    Bai L; Sun Y; Li S
    Chin Med J (Engl); 1997 Apr; 110(4):250-4. PubMed ID: 9594222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of bcl-2 mRNA and protein exression in hepatocellular carcinomas.
    Ravazoula P; Tsamandas AC; Kardamakis D; Gogos C; Karatza C; Thomopoulos K; Tepetes K; Kourelis T; Petsas T; Bonikos DS; Karavias D
    Anticancer Res; 2002; 22(3):1799-805. PubMed ID: 12168872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of expression of p21 and c-myc protein in hepatocellular carcinoma with pericarcinomatous liver tissue].
    Feng D; Cheng R; Yan Y
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):310-2. PubMed ID: 9868083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells.
    Jiang MC; Yang-Yen HF; Lin JK; Yen JJ
    Oncogene; 1996 Aug; 13(3):609-16. PubMed ID: 8760302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of HCV NS3 protein on expression of p53 gene protein in hepatocarcinogenesis].
    Feng D; Zheng H; Yan Y
    Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):278-80. PubMed ID: 10923485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [c-myc gene and p53 protein expression in human primary liver carcinoma].
    Cai DW; Gao CZ; Wang NJ
    Zhonghua Bing Li Xue Za Zhi; 1994 Apr; 23(2):100-3. PubMed ID: 8082236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.